Antaros Medical presents First-in-class PET tracer for the glucagon receptor at EASD 2017

Lisbon, 12 September Antaros Medical, in collaboration with Sanofi, presents important data at the 53rd Annual Meeting of the European […]

Antaros Medical presents data supporting Imiomics at the ESMO 2017 Congress

Madrid, 11 September Together with teams at Uppsala University, Antaros presented a poster with the title “Registration based automated lesion […]

Antaros Medical presented data at the 2nd NASH biomarkers workshop on the importance of assessing the entire liver when studying liver fat

Assoc Professor Lars Johansson, co-founder of Antaros Medical and Chief Scienctific Officer, together with Dr Chris Weyer, President and Chief […]

Antaros – partner in EU IMI collaboration TRISTAN focusing on imaging biomarkers for drug safety assessments

The EU Innovative Medicines Initiative (IMI) has approved TRISTAN, a 5-year project focusing on validation of translational imaging methods for […]

Career Opportunity – Imaging Analyst

Antaros is continuously growing. To deliver on our commitments, we are looking for people with analytical skills and a high […]

Career Opportunity – Director Clinical Trial Management

Antaros experience a steady growth. To deliver on our commitments, we are looking for people with both broad and deep experience […]

Antaros Medical is awarded prestigious prize by the city of Gothenburg

Antaros Medical AB is very proud of being awarded the Göteborgs Companipris 2016, a prize to successful companies developed in […]

Antaros Medical and Almi Invest adds 3 million SEK in venture capital to Emeriti Pharma

Emeriti Pharma, which is developing a new treatment for skin diseases, takes up two million in venture capital from Antaros […]

Next important steps for the new Oncology business area

Per Hagmar, MSc, PhD, appointed Senior Vice President Oncology and Business Development and Håkan Ahlström, Professor, M.D, one of the […]

Antaros Medical is joining the war against cancer

Antaros Medical were invited to introduce its recent oncology investment at the Red Eye event “Winning the war on cancer”, […]